The following is a summary of "Efficacy and safety of regorafenib in the treatment of bone sarcomas: systematic review and meta-analysis," published in the February 2025 issue of the BMC Cancer by Han ...

Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in ...

Experts discuss how they balance safety, efficacy, and overall patient prognosis when selecting third-line treatments for metastatic colorectal cancer (mCRC) and explore how the toxicity profiles of ...

Exelixis' future depends on trial outcomes and patent risks. Find out why EXEL stock is a "Sell" despite cabozantinib's ...

KFDA approves Takedas Prucalopride capsules for metastatic colorectal cancer Approval granted for Takedas Prucalopride ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...